User profiles for Hanna Najgebauer
Hanna NajgebauerWellcome Sanger Institute Verified email at sanger.ac.uk Cited by 540 |
[HTML][HTML] Integrated cross-study datasets of genetic dependencies in cancer
…, I Boyle, E Gonçalves, H Najgebauer… - Nature …, 2021 - nature.com
CRISPR-Cas9 viability screens are increasingly performed at a genome-wide scale across
large panels of cell lines to identify new therapeutic targets for precision cancer therapy. …
large panels of cell lines to identify new therapeutic targets for precision cancer therapy. …
[HTML][HTML] Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets
…, ST Younger, V Zhivich, H Najgebauer… - Nature …, 2019 - nature.com
Genome-scale CRISPR-Cas9 viability screens performed in cancer cell lines provide a
systematic approach to identify cancer dependencies and new therapeutic targets. As multiple …
systematic approach to identify cancer dependencies and new therapeutic targets. As multiple …
[HTML][HTML] CardioClassifier: disease-and gene-specific computational decision support for clinical genome interpretation
…, R Buchan, W Midwinter, AE Wilk, H Najgebauer… - Genetics in …, 2018 - nature.com
Purpose Internationally adopted variant interpretation guidelines from the American College
of Medical Genetics and Genomics (ACMG) are generic and require disease-specific …
of Medical Genetics and Genomics (ACMG) are generic and require disease-specific …
[HTML][HTML] An integrated landscape of protein expression in human cancer
Using 11 proteomics datasets, mostly available through the PRIDE database, we assembled
a reference expression map for 191 cancer cell lines and 246 clinical tumour samples, …
a reference expression map for 191 cancer cell lines and 246 clinical tumour samples, …
[PDF][PDF] CELLector: genomics-guided selection of cancer in vitro models
H Najgebauer, M Yang, HE Francies, C Pacini… - Cell systems, 2020 - cell.com
Selecting appropriate cancer models is a key prerequisite for maximizing translational
potential and clinical relevance of in vitro oncology studies. We developed CELLector: an R …
potential and clinical relevance of in vitro oncology studies. We developed CELLector: an R …
Integrated omics profiling reveals novel patterns of epigenetic programming in cancer-associated myofibroblasts
There is increasing evidence that stromal myofibroblasts play a key role in the tumour
development however, the mechanisms by which they become reprogrammed to assist in cancer …
development however, the mechanisms by which they become reprogrammed to assist in cancer …
[HTML][HTML] Integrative omic profiling reveals unique hypoxia induced signatures in gastric cancer associated myofibroblasts
H Najgebauer, AF Jarnuczak, A Varro, CM Sanderson - Cancers, 2019 - mdpi.com
Although hypoxia is known to contribute to several aspects of tumour progression, relatively
little is known about the effects of hypoxia on cancer-associated myofibroblasts (CAMs), or …
little is known about the effects of hypoxia on cancer-associated myofibroblasts (CAMs), or …
Redefining false discoveries in cancer data analyses
The nature of biological networks still brings challenges related to computational complexity,
interpretable results and statistical significance. Recent work proposes a new method that …
interpretable results and statistical significance. Recent work proposes a new method that …
CardioClassifier–demonstrating the power of disease-and gene-specific computational decision support for clinical genome interpretation
…, R Buchan, W Midwinter, AE Wilk, H Najgebauer… - bioRxiv, 2017 - biorxiv.org
Purpose Internationally-adopted variant interpretation guidelines from the American
College of Medical Genetics and Genomics (ACMG) are generic and require disease-specific …
College of Medical Genetics and Genomics (ACMG) are generic and require disease-specific …
Genome-Wide DNA Methylation and Gene Expression Profiling of Cancer-Associated Myofibroblasts
H Najgebauer - 2016 - livrepository.liverpool.ac.uk
In recent years it has become increasingly apparent that tumour development and metastasis
are not simply driven by mutations within cancer cells. Factors produced by stromal …
are not simply driven by mutations within cancer cells. Factors produced by stromal …